These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 22086555)

  • 21. Benzenediol-berberine hybrids: multifunctional agents for Alzheimer's disease.
    Jiang H; Wang X; Huang L; Luo Z; Su T; Ding K; Li X
    Bioorg Med Chem; 2011 Dec; 19(23):7228-35. PubMed ID: 22041172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease: β-amyloid plaque formation in human brain.
    Seeman P; Seeman N
    Synapse; 2011 Dec; 65(12):1289-97. PubMed ID: 21633975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper(II) coordination to amyloid β: murine versus human peptide.
    Eury H; Bijani C; Faller P; Hureau C
    Angew Chem Int Ed Engl; 2011 Jan; 50(4):901-5. PubMed ID: 21246687
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
    Shan WJ; Huang L; Zhou Q; Meng FC; Li XS
    Eur J Med Chem; 2011 Dec; 46(12):5885-93. PubMed ID: 22019228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifunctional fluorescent probe for effective visualization, inhibition, and detoxification of β-amyloid aggregation
    Zhang Z; Cao Y; Yuan Q; Liu C; Duan X; Tang Y
    Chem Commun (Camb); 2022 Mar; 58(24):3957-3960. PubMed ID: 35244642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of distinct physiochemical properties of toxic prefibrillar species formed by Aβ peptide variants.
    Göransson AL; Nilsson KP; Kågedal K; Brorsson AC
    Biochem Biophys Res Commun; 2012 Apr; 420(4):895-900. PubMed ID: 22475489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
    Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
    J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patients.
    Hosono-Fukao T; Ohtake-Niimi S; Hoshino H; Britschgi M; Akatsu H; Hossain MM; Nishitsuji K; van Kuppevelt TH; Kimata K; Michikawa M; Wyss-Coray T; Uchimura K
    Am J Pathol; 2012 May; 180(5):2056-67. PubMed ID: 22429964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silibinin: a novel inhibitor of Aβ aggregation.
    Yin F; Liu J; Ji X; Wang Y; Zidichouski J; Zhang J
    Neurochem Int; 2011 Feb; 58(3):399-403. PubMed ID: 21185897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dynamic nature of amyloid beta (1-40) aggregation.
    Belitzky A; Melamed-Book N; Weiss A; Raviv U
    Phys Chem Chem Phys; 2011 Aug; 13(30):13809-14. PubMed ID: 21725546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-Photon Absorbing Dyes with Minimal Autofluorescence in Tissue Imaging: Application to in Vivo Imaging of Amyloid-β Plaques with a Negligible Background Signal.
    Kim D; Moon H; Baik SH; Singha S; Jun YW; Wang T; Kim KH; Park BS; Jung J; Mook-Jung I; Ahn KH
    J Am Chem Soc; 2015 Jun; 137(21):6781-9. PubMed ID: 25951499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic approaches related to amyloid-beta peptide and Alzheimer's disease.
    Schenk DB; Rydel RE; May P; Little S; Panetta J; Lieberburg I; Sinha S
    J Med Chem; 1995 Oct; 38(21):4141-54. PubMed ID: 7473539
    [No Abstract]   [Full Text] [Related]  

  • 34. Toward understanding amyloid aggregation.
    Kominos D
    Biophys J; 1995 Sep; 69(3):739-40. PubMed ID: 8519974
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluorescence behavior of a unique two-photon fluorescent probe in aggregate and solution states and highly sensitive detection of RNA in water solution and living systems.
    Liu Y; Meng F; He L; Yu X; Lin W
    Chem Commun (Camb); 2016 Jul; 52(57):8838-41. PubMed ID: 27346863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer antibody drugs show questionable potential.
    Reardon S
    Nat Rev Drug Discov; 2015 Sep; 14(9):591-2. PubMed ID: 26323534
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial: A Is for Amyloid.
    Selkoe DJ
    J Prev Alzheimers Dis; 2020; 7(3):140-141. PubMed ID: 32463063
    [No Abstract]   [Full Text] [Related]  

  • 38. The Journey of 1-Keto-1,2,3,4-Tetrahydrocarbazole Based Fluorophores: From Inception to Implementation.
    Mitra AK
    J Fluoresc; 2022 Nov; 32(6):2023-2052. PubMed ID: 35829843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly reactive (<1 min) ratiometric "naked eye" detection of hypochlorite with real application in tap water.
    Goswami S; Paul S; Manna A
    Dalton Trans; 2013 Jul; 42(28):10097-101. PubMed ID: 23732748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why Amyloid Is Still a Target for Alzheimer Disease Clinical Trials.
    McDade E
    J Am Geriatr Soc; 2019 Apr; 67(4):845-847. PubMed ID: 30851119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.